Call Us: 1.800.873.5297

By

Transvaginal Mesh MDL Lawsuit Update: C.R. Bard Denied Request to Exclude Certain Documents at Trial

verdictsLaw 360 reports that The Honorable Judge Joseph Goodwin, who presides over the C.R. Bard Multidistrict Litigation (MDL) pending in the Southern District of West Virginia, has denied C.R. Bard’s motion requesting the exclusion of an employee’s proposed changes to vaginal mesh products as evidence based on the finding that they touched on the issue of plaintiff’s design defect claim.

C.R. Bard had requested that certain internal memorandums from one of C.R. Bard’s employees, and head of the advanced surgical concepts division – Bobby Orr, be excluded from trial. In particular, Orr had written the documents in 2008 and 2009 regarding the links to adverse events and proposed changes to improve the product design.

C.R. Bard argued that the documents were not relevant to the plaintiff’s design defect claim due to the fact that plaintiffs must show that a defect existed at the time the product left the company’s control, under Mississippi law. C.R. Bard argued that Orr wrote the memorandums at issue after the device was manufactured and implanted, they should be excluded. However, Judge Goodwin ruled that a design defect claim involves whether C.R. Bard knew or should have known of a risk and whether an alternative design was feasible, and the scientific literature referenced by Orr was published before C.R. Bard sold the mesh product that was implanted in the plaintiff. For these reasons, the judge allowed for parts of the documents to be admitted in court, depending on the particular foundation laid at trial and the specific portions of the memoranda that plaintiff seeks to introduce.

This ruling applies to the fourth bellwether case scheduled for trial in the C.R. Bard MDL (Jones v. C.R. Bard Inc. et al, Case No. 2:11-cv-00114). As we previously reported, the first bellwether case resulted in a $2 million damages award against C.R. Bard and the second bellwether case settled on the first day of trial. The third bellwether case was dropped back in September, weeks before a trial was supposed to begin.

Thousands of women allege that they have experienced complications from these transvaginal mesh devices, including device erosion, organ perforation, intense pain, inability to have sexual intercourse, infection, and the need to undergo multiple revision surgeries. As of now, over 37,000 transvaginal mesh lawsuits are currently pending in federal courts – and the number of cases continues to grow. According to the most recent report released by the Judicial Panel on Multidistrict Litigation (JPML), there are six Multidistrict Litigations (MDLs) involving different transvaginal mesh device manufacturers::

  • MDL 2187 – In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation: 5,516 pending cases
  • MDL 2325 – In re: American Medical Systems, Pelvic Repair System Products Liability Litigation: 11,402 pending cases
  • MDL 2326 – In re: Boston Scientific Corp. Pelvic Repair System Products Liability Litigation: 7,377 pending cases
  • MDL 2327 – In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation: 11,667 pending cases
  • MDL  2387 – In re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation: 1,106 pending cases
  • MDL 2440 – In re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation: 150 pending cases

If you or a loved one has experienced serious injuries as a result of a transvaginal mesh device, contact one of our experienced attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297. We will confidentially evaluate your case for free and without any obligation.

 

Legal Disclaimer: The choice of a lawyer is an important decision and should not be based solely on advertisements. The cases discussed do not predict outcomes in future cases. Past results afford no guarantee of future results and every case is different and must be judged on its own merits.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.